CH607919A5 - - Google Patents

Info

Publication number
CH607919A5
CH607919A5 CH953475A CH953475A CH607919A5 CH 607919 A5 CH607919 A5 CH 607919A5 CH 953475 A CH953475 A CH 953475A CH 953475 A CH953475 A CH 953475A CH 607919 A5 CH607919 A5 CH 607919A5
Authority
CH
Switzerland
Application number
CH953475A
Inventor
Miguel Angel Ondetti
Charles Riffkin
Bernard Rubin
Aaron Louis Weiss
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CH607919A5 publication Critical patent/CH607919A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH953475A 1974-07-22 1975-07-21 CH607919A5 (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/490,644 US3937819A (en) 1974-07-22 1974-07-22 Method of stabilizing an injectable composition of a cholecystokinin active octapeptide

Publications (1)

Publication Number Publication Date
CH607919A5 true CH607919A5 (en, 2012) 1978-12-15

Family

ID=23948914

Family Applications (1)

Application Number Title Priority Date Filing Date
CH953475A CH607919A5 (en, 2012) 1974-07-22 1975-07-21

Country Status (10)

Country Link
US (1) US3937819A (en, 2012)
JP (1) JPS5940143B2 (en, 2012)
BE (1) BE835289A (en, 2012)
CA (1) CA1054940A (en, 2012)
CH (1) CH607919A5 (en, 2012)
DE (1) DE2532740A1 (en, 2012)
DK (1) DK155777C (en, 2012)
FR (1) FR2279417A1 (en, 2012)
GB (1) GB1499029A (en, 2012)
SE (1) SE7508308L (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3061586D1 (en) * 1979-04-30 1983-02-17 Max Planck Gesellschaft Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
JPS5822474B2 (ja) * 1980-06-10 1983-05-09 天野製薬株式会社 コレシストキニン・パンクレオザイミンc端ペプチドアミドスルフエ−トエステルの製造法
US4400377A (en) * 1980-09-26 1983-08-23 Farmitalia Carlo Erba, S.P.A. Use of polypeptides as analgesic drugs
US4351829A (en) * 1980-09-26 1982-09-28 Farmitalia Carlo Erba Spa Use of polypeptides as analgesic drugs
JPS61172878A (ja) * 1985-01-28 1986-08-04 Sankyo Co Ltd カルバペネム誘導体の安定な凍結乾燥製剤の製法
US5495851A (en) * 1995-03-23 1996-03-05 Roanoke Gastroenterology, P.C. Use of endoscopic ultrasound and stimulated bilary drainage in the diagnosis of cholecystitis and microlithiasis
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
US7690395B2 (en) * 2004-01-12 2010-04-06 Masco Corporation Of Indiana Multi-mode hands free automatic faucet
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734946A (en) * 1969-12-23 1973-05-22 Squibb & Sons Inc Serine derivatives
US3723406A (en) * 1969-12-23 1973-03-27 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor

Also Published As

Publication number Publication date
DK155777C (da) 1989-10-30
CA1054940A (en) 1979-05-22
DE2532740A1 (de) 1976-02-12
US3937819A (en) 1976-02-10
SE7508308L (sv) 1976-01-23
JPS5940143B2 (ja) 1984-09-28
FR2279417B1 (en, 2012) 1978-11-10
GB1499029A (en) 1978-01-25
DK330575A (da) 1976-01-23
JPS5141356A (en, 2012) 1976-04-07
DK155777B (da) 1989-05-16
FR2279417A1 (fr) 1976-02-20
BE835289A (fr) 1976-05-05

Similar Documents

Publication Publication Date Title
AU477223B2 (en, 2012)
FR2260386A1 (en, 2012)
FI751236A7 (en, 2012)
FR2279417B1 (en, 2012)
FI752484A7 (en, 2012)
FR2258693B1 (en, 2012)
FR2261968B1 (en, 2012)
AR198563A1 (en, 2012)
AU7138274A (en, 2012)
AU7474374A (en, 2012)
AU6599774A (en, 2012)
CS166387B1 (en, 2012)
CS166095B1 (en, 2012)
CS168312B1 (en, 2012)
DD116735A1 (en, 2012)
BG20039A1 (en, 2012)
BE830156A (en, 2012)
BG19564A1 (en, 2012)
BG19621A1 (en, 2012)
BG19899A1 (en, 2012)
BG19703A1 (en, 2012)
DD121676A5 (en, 2012)
DD120481A5 (en, 2012)
AU482022A (en, 2012)
DD115901A1 (en, 2012)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased